The global clinical nutrition market size was valued at USD 34.04 billion in 2025 and is expected to grow at a CAGR of 5.27% to reach a value of USD 51.47 billion in 2033. This growth is driven by the rising prevalence of malnutrition, increasing demand for post-cancer care, and a consumer shift toward plant-based options, along with the launch of such solutions by notable players such as Nutricia and Nestlé. The rising prevalence of malnutrition and undernutrition is expected to significantly drive demand for clinical nutrition solutions, as governments, NGOs, and healthcare providers focus on addressing nutritional deficiencies and improving health outcomes in vulnerable populations.
Both established and emerging companies are adopting strategic initiatives, including partnerships & launch of new products, to expand their market presence.
For instance: In July 2022, Danone, as stated in the press release, launched the first-ever dairy and plants blend baby formula in response to parents’ demand for vegetarian & flexitarian options for their babies. The consumption of plant-based products is significantly growing, with over one-third (37%) of EU consumers opting for a vegan, vegetarian, or flexitarian diet. In addition, almost 70% (69%) of parents now prefer their children to consume more plant-based foods.
“At Danone, we recognize many parents want to introduce plant-based, vegetarian, and flexitarian options into their baby’s diet, while still meeting their baby’s specific nutritional requirements. Our new Dairy & Plants Blend baby formula has been developed with these needs top of mind.”
-Manuela Borella, Vice President, Global Plant Based Strategy & Business Acceleration, Nutricia's parent company Danone
In May 2022, Nestlé Health Science (NHSc) agreed to acquire Puravida to expand the NHSc portfolio of the nutrition segment in Brazil. The nutrition portfolio will include minerals, herbal & vitamin supplements, and nutritional beverages using plant-based foods. Eventually, this is likely to enhance the nutritional content and quality of the supplements. In addition, companies such as ByHeart are utilizing product launch strategies to differentiate themselves in the market and transition from a volume-based to a value-based approach. For instance,
In March 2022, ByHeart launched its groundbreaking Infant Formula, making it the only new infant formula brand in decades to reevaluate & reconstruct the recipe. The company's countrywide clinical trial demonstrated benefits closely resembling breast milk. The formula features a patented blend of the two most abundant proteins in breast milk, along with organic, grass-fed whole milk, emphasizing its distinctiveness in the market.
Moreover, Kabrita USA (a division of Ausnutria), which is recognized for its toddler formula made with goat milk sold in the U.S. since 2014, is anticipated to enter the infant formula market by introducing a new product made with goat milk sourced from the Netherlands.
Kabrita USA launched its goat milk-based infant formula in the U.S. after a decade-long process to secure GRAS status for its goat milk ingredients and ensure the product meets all FDA nutrient requirements. The company is emphasizing scientific education to parents on goat milk’s nutritional profile which is said to more closely resemble breast milk than traditional cow-milk formulas as it rolls the product out through online channels and select retailers nationwide
“Goat milk infant formula has been beloved by parents around the world, and finally parents in the U.S. can feed their babies with a trusted product, based on the highest quality Dutch goat milk that is legally imported to the U.S.”
- Dr Ari Brown, MD, FAAP Renowned pediatrician and bestselling author of the baby 411 series.
|
Price (USD/Standardized Unit) |
|||
|
Country |
RTD & Liquid Feed (per 500ml) |
Oral Feed & Powdered (per 100g) |
Capsules & Tablets (per 60 caps) |
|
U.S. |
22.5 |
11.8 |
39.8 |
|
Canada |
22.3 |
11.7 |
39.6 |
|
Germany |
21.0 |
10.9 |
37.1 |
|
UK |
The in-depth insights around the pricing analysis will be provided in the final deliverable. |
||
|
France |
|||
|
Italy |
|||
|
Spain |
|||
|
China |
|||
|
Japan |
|||
|
India |
|||
|
Australia |
|||
|
Singapore |
|||
|
New Zealand |
|||
|
South Korea |
|||
|
Brazil |
|||
|
Mexico |
|||
|
Argentina |
|||
|
South Africa |
|||
|
Saudi Arabia |
|||
|
UAE |
|||
|
Finland |
|||
|
Czech Republic |
|||
|
Hungary |
|||
|
Vietnam |
|||
|
Company |
Estimated Company Market Share, 2025 (%) |
|
Nestle |
12.76% - 16.76% |
|
Abbott |
The in-depth insights will be provided in the final deliverable. |
|
Danone |
|
|
Fresenius Kabi |
|
|
Mead Johnson & Company, LLC (acquired by Reckitt Benckiser Group PLC) |
|
|
Others (Meiji Holdings. Co., Ltd., Ausnutria Dairy Corporation Ltd., etc.) |
|
Company |
Estimated Company Market Share, 2025 (%) |
|
Baxter |
The in-depth insights will be provided in the final deliverable. |
|
Fresenius Kabi AG |
|
|
Baxter |
|
|
Pfizer Inc. |
|
|
Grifols, S.A. |
|
|
Otsuka Holdings Co., Ltd. |
|
|
Others (B.Braun, etc.) |
The sales revenue of medical foods sold through online and retail channels is estimated based on Nestlé Group’s Nutrition & Health Science segment performance through 2024. Channel mix assumptions incorporate continued acceleration in direct-to-consumer (DTC) platforms, stabilization of pharmacy-led retail sales, and normalization of hospital procurement post-pandemic. E-commerce penetration has continued to expand, supported by subscription models, digital nutrition programs, and platform-led promotions.
|
Online Channels |
Estimated % Revenue |
Insights |
|
Amazon |
65%-70% |
Amazon remains the dominant online channel, supported by subscription-based purchases (e.g., Ensure, Boost) and high visibility across U.S. and European markets. However, its relative share has marginally declined due to rising DTC penetration. |
|
Nestlé Nutrition Store (DTC) |
The in-depth insights around the sales channel analysis will be provided in the final deliverable. |
|
|
NetMeds & Regional Pharmacies |
||
|
Others |
||
|
Retail Channels |
Estimated % Revenue |
Insights |
|
Pharmacies/ Drug stores |
45%-50% |
Pharmacies remain a key channel due to physician-led recommendations, reimbursement-linked purchases, and aging demographics. |
|
Department Store |
50%-55% |
Modern retail continues to benefit from bundled promotions and wider shelf presence, though growth is slower than online channels. |
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent..."